Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1976 1
1977 1
1981 1
1992 1
1993 3
1995 1
2000 1
2006 1
2009 1
2014 1
2015 3
2016 3
2017 2
2018 1
2019 4
2020 5
2021 1
2022 2
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
BACKGROUND: Bapineuzumab, a humanized anti-amyloid-beta monoclonal antibody, is in clinical development for the treatment of Alzheimer's disease. METHODS: We conducted two double-blind, randomized, placebo-controlled, phase 3 trials involving patients with mild-to-moderate …
BACKGROUND: Bapineuzumab, a humanized anti-amyloid-beta monoclonal antibody, is in clinical development for the treatment of Alzheimer's
Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT).
Bernhardt J, Churilov L, Ellery F, Collier J, Chamberlain J, Langhorne P, Lindley RI, Moodie M, Dewey H, Thrift AG, Donnan G; AVERT Collaboration Group. Bernhardt J, et al. Neurology. 2016 Jun 7;86(23):2138-45. doi: 10.1212/WNL.0000000000002459. Epub 2016 Feb 17. Neurology. 2016. PMID: 26888985 Free PMC article. Clinical Trial.
The influence of social media on recruitment to surgical trials.
Bisset CN, Carter B, Law J, Hewitt J, Parmar K, Moug SJ; ELF Study Group Collaborative Authorship. Bisset CN, et al. BMC Med Res Methodol. 2020 Jul 28;20(1):201. doi: 10.1186/s12874-020-01072-1. BMC Med Res Methodol. 2020. PMID: 32723388 Free PMC article.
CONCLUSION: The ELF Study over-recruited by nearly 100%, reaching over 200,000 people across the U.K. Branding enhanced tweet aesthetics and helped increase tweet engagement to stimulate discussion and healthy competition amongst clinicians to aid trial recruitment. ...
CONCLUSION: The ELF Study over-recruited by nearly 100%, reaching over 200,000 people across the U.K. Branding enhanced tweet aesthet …
Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report.
Miller MS, Allen P, Brentnall TA, Goggins M, Hruban RH, Petersen GM, Rao CV, Whitcomb DC, Brand RE, Chari ST, Klein AP, Lubman DM, Rhim AD, Simeone DM, Wolpin BM, Umar A, Srivastava S, Steele VE, Rinaudo JA. Miller MS, et al. Pancreas. 2016 Sep;45(8):1080-91. doi: 10.1097/MPA.0000000000000705. Pancreas. 2016. PMID: 27518363 Free PMC article.
Effect of work boot shaft stiffness and sole flexibility on boot clearance and shank muscle activity when walking on simulated coal mining surfaces: implications for reducing trip risk.
Dobson JA, Riddiford-Harland DL, Bell AF, Wegener C, Steele JR. Dobson JA, et al. Ergonomics. 2022 Aug;65(8):1071-1085. doi: 10.1080/00140139.2021.2016996. Epub 2022 Jan 10. Ergonomics. 2022. PMID: 34882520
Despite the potential negative consequences associated with tripping, limited research has investigated how these boot design features might contribute to a miner's trip risk. Therefore, this study aimed to investigate the effects of systematic variations to boot shaft sti …
Despite the potential negative consequences associated with tripping, limited research has investigated how these boot design features might …
Impatience in casualty?
Brand IA, Steele SK, Swinden LB, Walter JE. Brand IA, et al. Aust Hosp. 1977 Feb;(5):6-7. Aust Hosp. 1977. PMID: 10242765 No abstract available.
Comparison of nebuliser efficiency for aerosolizing pentamidine.
Smith D, Erskine D, Steele J, Hills D, Gazzard B. Smith D, et al. J Pharm Pharmacol. 1992 Jan;44(1):7-9. doi: 10.1111/j.2042-7158.1992.tb14353.x. J Pharm Pharmacol. 1992. PMID: 1350636
Inhaled pentamidine has become an important method of treatment and prophylaxis for Pneumocystis carinii pneumonia and we have compared nebuliser efficiency in terms of drug output and droplet sizes in four brands of jet nebuliser (Acorn-22, Inspiron, Cirrus, Respirgard II …
Inhaled pentamidine has become an important method of treatment and prophylaxis for Pneumocystis carinii pneumonia and we have compared nebu …
31 results